Lantern Pharma logo

Lantern Pharma Share Price (NASDAQ: LTRN)

$4.35

-0.11

(-2.47%)

Live

Last updated on

Check the interactive Lantern Pharma Stock chart to analyse performance

Lantern Pharma stock performance

as on August 21, 2025 at 1:29 AM IST

  • Today's Low:$4.19
    Today's High:$4.39

    Day's Volatility :4.56%

  • 52 Weeks Low:$2.55
    52 Weeks High:$6.12

    52 Weeks Volatility :58.32%

Lantern Pharma Stock Returns

PeriodLantern Pharma IncSector (Health Care)Index (Russel 2000)
3 Months
31.44%
1.5%
0.0%
6 Months
-5.39%
-7.1%
0.0%
1 Year
-0.23%
-11.4%
0.0%
3 Years
-23.25%
2.9%
-9.6%

Lantern Pharma Inc Key Stats

Check Lantern Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.46
Open
$4.38
Today's High
$4.51
Today's Low
$4.19
Market Capitalization
$47.9M
Today's Volume
$39.1K
52 Week High
$6.118
52 Week Low
$2.55
Revenue TTM
$0.0
EBITDA
$-20.5M
Earnings Per Share (EPS)
$-1.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-88.59%

Stock Returns calculator for Lantern Pharma Stock including INR - Dollar returns

The Lantern Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lantern Pharma investment value today

Current value as on today

₹1,02,752

Returns

₹2,752

(+2.75%)

Returns from Lantern Pharma Stock

₹1,136 (-1.14%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Lantern Pharma Stock

9%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Lantern Pharma Stock from India on INDmoney has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lantern Pharma Inc

  • Name

    Holdings %

  • BIOS CAPITAL MANAGEMENT, LP

    11.20%

  • Vanguard Group Inc

    3.37%

  • CM Management, LLC

    1.85%

  • Geode Capital Management, LLC

    0.84%

  • Renaissance Technologies Corp

    0.82%

  • Goss Wealth Management LLC

    0.56%

Analyst Recommendation on Lantern Pharma Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Lantern Pharma(by analysts ranked 0 to 5 stars)

Lantern Pharma Share Price Target

What analysts predicted

Upside of 405.75%

Target:

$22.00

Current:

$4.35

Lantern Pharma share price target is $22.00, a slight Upside of 405.75% compared to current price of $4.35 as per analysts' prediction.

Lantern Pharma Stock Insights

  • Price Movement

    In the last 7 days, LTRN stock has moved down by -7.8%
  • LTRN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 63.5%
  • LTRN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.3% return, outperforming this stock by 133.9%

Lantern Pharma Technicals Summary

Sell

Neutral

Buy

Lantern Pharma is currently in a neutral trading position according to technical analysis indicators.

Lantern Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lantern Pharma Inc logo
15.83%
-5.39%
-0.23%
-23.25%
-73.55%
Regeneron Pharmaceuticals, Inc. logo
4.65%
-16.73%
-52.11%
-6.73%
-5.71%
Beone Medicines Ltd logo
7.16%
32.17%
61.08%
80.84%
30.07%
Vertex Pharmaceuticals Incorporated logo
-14.79%
-17.19%
-19.84%
32.96%
44.01%
Alnylam Pharmaceuticals, Inc. logo
43.03%
83.01%
63.29%
110.39%
235.62%

About Lantern Pharma Inc

Lantern Pharma Inc. focuses on the discovery and development of oncology drug. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1 clinical trial for the treatment of solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central nervous system (CNS) cancers; and LP-284, which is in phase 1 clinical trial for the treatment of non-Hodgkin's lymphomas, including mantle cell lymphoma and double hit lymphoma. The company also develops STAR-001, which is in preclinical development for the treatment of glioblastoma, brain metastases, atypical teratoid rhabdoid tumors, and several rare pediatric CNS cancers. In addition, it provides ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. The company has a strategic AI-driven collaboration with Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications; a collaboration agreement with TTC Oncology, which focuses on the drug development of TTC-352 to treat patients with metastatic ER+ breast cancer; and a collaboration agreement with Actuate Therapeutics, Inc. that focuses on the development of compounds for use in the treatment of cancer and inflammatory diseases. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Organization
Lantern Pharma
Employees
24
CEO
Mr. Panna Sharma
Industry
Commercial Services

Key Management of Lantern Pharma Inc

NameTitle
Mr. Panna Sharma
President, CEO & Director
Mr. David R. Margrave
CFO & Secretary
Dr. Kishor Gopaldas Bhatia Ph.D.
Chief Scientific Officer & Scientific Consultant
Dr. Peter L. Nara D.V.M., M.S., Ph.D.
Co-Founder & Advisor
Mr. Ernest Kitt B.S., M.S
Head of Clinical Operations
Dr. Marc C. Chamberlain M.D.
Chief Medical Officer of Starlight Therapeutics

Important FAQs about investing in LTRN Stock from India :

What is Lantern Pharma share price today?

Lantern Pharma share price today is $4.35 as on . Lantern Pharma share today touched a day high of $4.39 and a low of $4.19.

What is the 52 week high and 52 week low for Lantern Pharma share?

Lantern Pharma share touched a 52 week high of $6.12 and a 52 week low of $2.55. Lantern Pharma stock price today i.e. is trending at $4.35, lower by 28.9% versus the 52 week high.

How to invest in Lantern Pharma Stock (LTRN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lantern Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lantern Pharma Shares that will get you 0.3448 shares as per Lantern Pharma share price of $4.35 per share as on August 21, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Lantern Pharma Stock (LTRN) from India?

Indian investors can start investing in Lantern Pharma (LTRN) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Lantern Pharma stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Lantern Pharma share’s latest price of $4.35 as on August 21, 2025 at 1:29 AM IST, you will get 2.2989 shares of Lantern Pharma. Learn more about fractional shares .

What are the returns that Lantern Pharma has given to Indian investors in the last 5 years?

Lantern Pharma stock has given -73.55% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?